VHL Peptide
Von Hippel Lindau Peptide
Product description
VHL,Von Hippel Lindau is involved in the ubiquitination and subsequent proteasomal degradation of hydroxylated hypoxia-inducible factor (HIF) under normoxic conditions. Defects in VHL are the cause of different types of cancers (pheochromocytoma, von Hippel-Lindau disease) and erythrocytosis.
Appearance | N/A |
---|---|
Molecular weight | N/A |
Purity | >95% |
Solubility | Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile. |
Synonyms | Von Hippel-Lindau disease tumor suppressor; pVHL; G7 protein; VHL |
Storage | -20℃, protected from light and moisture |
Transportation | 4-25℃ temperature for up to 2 weeks |
Stability | 1 year |
Document
Related Product